SFA Theraputics

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Morphic Therapeutic

This biopharmaceutical company develops oral integrin therapies for patients with serious chronic diseases, including autoimmune conditions, fibrosis, and inflammatory bowel disease.

Promakhos

This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.